Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia
- PMID: 6631444
- DOI: 10.1016/0022-510x(83)90157-0
Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia
Abstract
Plasma and cerebrospinal fluid (CSF) from 20 patients with Alzheimer's dementia or senile dementia of Alzheimer type (AD/SDAT), 23 with multi-infarct dementia (MID) and 16 controls were assayed for their content of immunoglobulins (Ig) and albumin (Alb). The concentrations of IgG and Alb were used to analyze the blood-CSF barrier function in the respective group. MID patients had significantly (P less than 0.001) elevated plasma IgG levels compared to controls and AD/SDAT patients. CSF concentration of Alb was significantly higher in MID (P less than 0.01) and AD/SDAT (P less than 0.05) patients compared to the controls. Concentration of CSF IgG was significantly (P less than 0.05) lower in AD/SDAT patients compared to the MID patients; no significant differences were found when CSF concentrations of IgG of demented patients were compared to controls. These findings may indicate a blood-CSF barrier dysfunction especially in cases with MID with significantly (P less than 0.001) elevated values of transudation. Also these findings indicate a non-specific and/or specific binding of IgG in CNS tissue and/or vessel walls in both forms of dementia on the basis of low IgG ratios compared to proportionally higher Alb ratios. There were no signs of local synthesis of IgG in CNS in either group of demented patients.
Similar articles
-
The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid.J Neurol Sci. 1985 Feb;67(2):253-61. doi: 10.1016/0022-510x(85)90121-2. J Neurol Sci. 1985. PMID: 3981221
-
Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.Eur Neurol. 1987;26(4):229-34. doi: 10.1159/000116341. Eur Neurol. 1987. PMID: 3595662
-
Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias.Acta Neurol Scand. 1991 Sep;84(3):210-3. doi: 10.1111/j.1600-0404.1991.tb04940.x. Acta Neurol Scand. 1991. PMID: 1950463
-
Amino acid concentrations in cerebrospinal fluid in presenile and senile dementia of Alzheimer type and multi-infarct dementia.Arch Gerontol Geriatr. 1989 Sep-Oct;9(2):123-35. doi: 10.1016/0167-4943(89)90033-2. Arch Gerontol Geriatr. 1989. PMID: 2686573 Review.
-
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.J Neurol Sci. 2001 Mar 1;184(2):101-22. doi: 10.1016/s0022-510x(00)00501-3. J Neurol Sci. 2001. PMID: 11239944 Review.
Cited by
-
Possible factors in the etiology of Alzheimer's disease.Mol Neurobiol. 1994 Aug-Dec;9(1-3):1-13. doi: 10.1007/BF02816099. Mol Neurobiol. 1994. PMID: 7888085 Review.
-
Rationalising the role of Keratin 9 as a biomarker for Alzheimer's disease.Sci Rep. 2016 Mar 14;6:22962. doi: 10.1038/srep22962. Sci Rep. 2016. PMID: 26973255 Free PMC article.
-
Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.Brain. 2021 Jun 22;144(5):1361-1371. doi: 10.1093/brain/awab003. Brain. 2021. PMID: 34000009 Free PMC article.
-
Alzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid.Acta Neuropathol. 1991;82(1):6-12. doi: 10.1007/BF00310917. Acta Neuropathol. 1991. PMID: 1659107
-
Effect of age and monosodium-L-glutamate (MSG) treatment on neurotransmitter content in brain regions from male Fischer-344 rats.Neurochem Res. 1990 Sep;15(9):889-98. doi: 10.1007/BF00965908. Neurochem Res. 1990. PMID: 1980344
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous